RE:RE:RE:RE:PwC sees continuation of US$ 5 to 15 Billion Bio M&A Deals With 2 identified registration trials and potentially more to come, I think that an acquisition price for ONCY somewhere north of US$8 Billion is quite reasonable given Big Pharma's M&A "sweet-spot" acquisition range.